AIM: To evaluate the diagnostic potential of Lugol's chromoendoscopy-guided confocal laser endomicroscopy (CLE) in detecting superficial esophageal squamous cell neoplasia (ESCN). METHODS: Between December 2008 and September 2010, a total of 52 patients were enrolled at the Chinese PLA General Hospital in Beijing, China. First, Lugol's chromoendoscopy-guided CLE was performed in these patients and the CLE in vivo histological diagnosis was recorded. Then, chromoendoscopy-guided biopsy was performed in the same patients by another endoscopist who was blinded to the CLE findings. Based on the biopsy and CLE diagnosis, en bloc endoscopic resection was performed. The CLE in vivo diagnosis and the histological diagnosis of biopsy of ESCN were compared, using a histological examination of the endoscopic resection specimens as the standard reference. RESULTS: A total of 152 chromoendoscopy-guided biopsies were obtained from 56 lesions. In the 56 lesions of 52 patients, a total of 679 CLE images were obtained vs 152 corresponding biopsies. The sensitivity, specificity, negative predictive value and positive predictive value of chromoendoscopy-guided CLE compared with biopsy were 95.7% vs 82% (P < 0.05), 90% vs 70% (P < 0.05), 81.8% vs 46.7% (P < 0.05), and 97.8% vs 92.7% (P > 0.05), respectively. There was a significant improvement in sensitivity, specificity, negative predictive value, and accuracy when comparing chromoendoscopy-guided CLE with biopsy. CONCLUSION: Lugol's chromoendoscopy-guided CLE is a real-time, non-invasive endoscopic diagnostic technology; the accuracy of the detection of superficial ESCN is equivalent to or may be superior to biopsy histology.
AIM: To evaluate the diagnostic potential of Lugol's chromoendoscopy-guided confocal laser endomicroscopy (CLE) in detecting superficial esophageal squamous cell neoplasia (ESCN). METHODS: Between December 2008 and September 2010, a total of 52 patients were enrolled at the Chinese PLA General Hospital in Beijing, China. First, Lugol's chromoendoscopy-guided CLE was performed in these patients and the CLE in vivo histological diagnosis was recorded. Then, chromoendoscopy-guided biopsy was performed in the same patients by another endoscopist who was blinded to the CLE findings. Based on the biopsy and CLE diagnosis, en bloc endoscopic resection was performed. The CLE in vivo diagnosis and the histological diagnosis of biopsy of ESCN were compared, using a histological examination of the endoscopic resection specimens as the standard reference. RESULTS: A total of 152 chromoendoscopy-guided biopsies were obtained from 56 lesions. In the 56 lesions of 52 patients, a total of 679 CLE images were obtained vs 152 corresponding biopsies. The sensitivity, specificity, negative predictive value and positive predictive value of chromoendoscopy-guided CLE compared with biopsy were 95.7% vs 82% (P < 0.05), 90% vs 70% (P < 0.05), 81.8% vs 46.7% (P < 0.05), and 97.8% vs 92.7% (P > 0.05), respectively. There was a significant improvement in sensitivity, specificity, negative predictive value, and accuracy when comparing chromoendoscopy-guided CLE with biopsy. CONCLUSION: Lugol's chromoendoscopy-guided CLE is a real-time, non-invasive endoscopic diagnostic technology; the accuracy of the detection of superficial ESCN is equivalent to or may be superior to biopsy histology.
Authors: Ralf Kiesslich; Liebwin Gossner; Martin Goetz; Alexandra Dahlmann; Michael Vieth; Manfred Stolte; Arthur Hoffman; Michael Jung; Bernhard Nafe; Peter R Galle; Markus F Neurath Journal: Clin Gastroenterol Hepatol Date: 2006-07-13 Impact factor: 11.382
Authors: A Yokoyama; T Ohmori; H Makuuchi; K Maruyama; K Okuyama; H Takahashi; T Yokoyama; K Yoshino; M Hayashida; H Ishii Journal: Cancer Date: 1995-09-15 Impact factor: 6.860
Authors: Claudio L Hashimoto; Kiyoshi Iriya; Elisa R Baba; Tomas Navarro-Rodriguez; Maria C Zerbini; Jaime N Eisig; Ricardo Barbuti; Decio Chinzon; Joaquim Prado P Moraes-Filho Journal: Am J Gastroenterol Date: 2005-02 Impact factor: 10.864
Authors: Adrian L Polglase; Wendy J McLaren; Stewart A Skinner; Ralf Kiesslich; Markus F Neurath; Peter M Delaney Journal: Gastrointest Endosc Date: 2005-11 Impact factor: 9.427
Authors: Y Kakeji; S Yamaguchi; D Yoshida; K Tanoue; M Ueda; A Masunari; T Utsunomiya; M Imamura; H Honda; Y Maehara; M Hashizume Journal: Endoscopy Date: 2006-09 Impact factor: 10.093
Authors: Oliver Pech; Thomas Rabenstein; Hendrik Manner; Maria C Petrone; Jürgen Pohl; Michael Vieth; Manfred Stolte; Christian Ell Journal: Clin Gastroenterol Hepatol Date: 2007-12-11 Impact factor: 11.382
Authors: S M Dawsey; D E Fleischer; G Q Wang; B Zhou; J A Kidwell; N Lu; K J Lewin; M J Roth; T L Tio; P R Taylor Journal: Cancer Date: 1998-07-15 Impact factor: 6.860
Authors: Marek Kollar; Jana Krajciova; Lucia Prefertusova; Eva Sticova; Jana Maluskova; Zuzana Vackova; Jan Martinek Journal: United European Gastroenterol J Date: 2020-01-28 Impact factor: 4.623